ELV

Business Context and Reporting Period

This summary covers the Annual Report on Form 10-K for WellPoint, Inc. (now Elevance Health) for the fiscal year ended December 31, 2008. WellPoint is the largest health benefits company in the United States by medical membership, serving approximately 35.0 million members. The company operates as an independent licensee of the Blue Cross and Blue Shield Association (BCBSA) in 13 states and nationally as UniCare. It manages operations through three reportable segments: Commercial, Consumer, and Other.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Decline: Net income decreased by 26% ($854.7 million) and diluted EPS fell 14% ($0.80) compared to 2007. This was primarily driven by higher medical costs, net realized investment losses of $1.18 billion, and an intangible asset impairment charge of $141.4 million.
• Investment Losses: The company recorded significant other-than-temporary impairments (OTTI) totaling $1.2 billion, largely due to the financial crisis impacting Freddie Mac, Fannie Mae, and Lehman Brothers.
• Medical Cost Trends: The benefit expense ratio increased by 120 basis points to 83.6%, driven by higher medical costs in Local Group fully-insured and Medicare Advantage businesses.
• Membership Shifts: Total medical membership grew slightly by 1% (240,000 members). However, fully-insured membership declined by 3% while self-funded membership increased by 4%.
• Tax Benefits: A significant tax benefit of $0.90 per diluted share was recorded due to settlements with the IRS and changes in state tax apportionment factors, partially offsetting the decline in operating income.

Guidance, Outlook, and Risks

• CMS Sanctions: On January 12, 2009, the Centers for Medicare & Medicaid Services (CMS) suspended WellPoint from marketing to and enrolling new patients in Medicare Advantage and Medicare Part D plans until remediation efforts were confirmed. This does not affect current members.
• Regulatory Environment: The company faces significant uncertainty regarding health care reform legislation, potential changes to Medicare/Medicaid reimbursement, and state-level regulatory actions.
• Investment Risk: Due to market volatility, there is a continuing risk of further declines in the fair value of investment securities, which could lead to additional material OTTI charges in future periods.
• Liquidity: Despite market disruption, the company maintains strong liquidity with $17.4 billion in cash and investments. It reduced commercial paper outstanding to $0.9 billion and has a $2.4 billion senior credit facility available.
• Capital Allocation: The company repurchased approximately 56.4 million shares for $3.3 billion in 2008. As of December 31, 2008, $1.0 billion remained authorized for future repurchases.

Investor Verification Checklist

• Investment Portfolio Health: Verify the extent of unrealized losses in the $14.5 billion investment portfolio and the potential for future other-than-temporary impairment charges.
• Medical Cost Trends: Monitor the development of medical cost trends in the Local Group and Medicare Advantage segments to assess future margin pressure.
• CMS Remediation: Track the progress of remediation efforts with CMS to determine when the suspension on new Medicare Advantage/Part D enrollments will be lifted.
• Intangible Asset Valuation: Review the valuation of State-Sponsored licenses and goodwill, particularly given the $141.4 million impairment charge already taken in 2008.
• Regulatory Exposure: Assess the potential financial impact of pending health care reform legislation and state-level investigations (e.g., California rescission practices, New York out-of-network reimbursement).